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Abstract
Cytochrome P450 (CYP) enzymes for which there is no functional information are considered 
“orphan” CYPs. Previous studies showed that CYP20A1, an orphan, is expressed in human 
hippocampus and substantia nigra, and in zebrafish (Danio rerio) CYP20A1 maternal transcript 
occurs in eggs, suggesting involvement in brain and in early development. Moreover, 
hyperactivity is reported in humans with chromosome 2 microdeletions including CYP20A1. We 
examined CYP20A1 in zebrafish, including impacts of chemical exposure on expression. 
Zebrafish CYP20A1 cDNA was cloned, sequenced, and aligned with cloned human CYP20A1 
and predicted vertebrate orthologs. CYP20A1s share a highly conserved N-terminal region and 
unusual sequences in the I-helix and the heme-binding CYP signature motifs. CYP20A1 mRNA 
expression was observed in adult zebrafish organs including liver, heart, gonads, spleen and brain, 
as well as eye and optic nerve. Putative binding sites in proximal promoter regions of CYP20A1s, 
and response of zebrafish CYP20A1 to selected nuclear and xenobiotic receptor agonists, point to 
up-regulation by agents involved in steroid hormone response, cholesterol and lipid metabolism. 
There also was a dose-dependent reduction of CYP20A1 expression in embryos exposed to 
environmentally relevant levels of methylmercury. Morpholino knockdown of CYP20A1 in 
developing zebrafish resulted in behavioral effects, including hyperactivity and a slowing of the 
optomotor response in larvae. The results suggest that altered expression of CYP20A1 might be 
part of a mechanism linking methylmercury exposure to neurobehavioral deficits. The expanded 
information on CYP20A1 brings us closer to “deorphanization”, that is, identifying CYP20A1 
functions and its roles in health and disease.
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Introduction
In animals, enzymes of the cytochrome P450 (CYP) superfamily (Nelson, 2009) catalyze 
oxidation reactions as well as reductions and rearrangements with a vast array of 
endogenous and exogenous compounds, often with high regio- and stereo-selectivity (Lamb 
and Waterman, 2013). These activities serve a wide range of physiological and toxicological 
functions. In vertebrate genomes, the number of protein-coding CYP genes range from 
around 40 to more than 100, in 19 gene families (Nelson et al., 2013). While functions are 
known for many human CYPs, the physiological substrate(s) and function of a substantial 
number of vertebrate CYPs remain unknown. In humans, these so-called “orphan P450s” 
notably include CYP4F22, CYP4V2 and CYP20A1 (Stark and Guengerich, 2007). In the 
model species zebrafish (Danio rerio), there are few CYPs for which function has been 
shown. Functions can be inferred for many CYPs in gene families 5-51, based on activities 
of known mammalian orthologs, yet predicted function has been confirmed in few cases 
(e.g., the lanosterol 14α-demethylase CYP51) (Morrison et al., 2014). In gene families 1-3, 
there has been much lineage specific expansion, resulting in co-orthologs, most with 
unknown function (Kubota et al., 2013). Thus, many zebrafish CYPs still are properly 
considered orphans, including CYP20A1.
The sole member of the CYP20 family, CYP20A1, is found in a single copy in human, 
zebrafish and other vertebrate genomes sequenced to date. The catalytic function of 
CYP20A1 is unknown. Recombinant human CYP20A1 has been tested for activity (Stark et 
al., 2008), however, no oxidation reaction was detected with several endogenous compounds 
(steroids, fatty acids, neurotransmitters) or exogenous chemicals (i.e., terfenadine, 
clotrimazole) that are substrates for some other CYPs. Although limited information is 
available on this orphan P450, it was found to be relatively highly expressed in human 
hippocampus and substantia nigra (Stark et al., 2008). These two brain regions are 
associated with learning and memory, and are involved in neurodegenerative diseases 
(Wirdefeldt et al., 2011; Zhou et al., 2008). High levels of CYP20A1 transcript occur also in 
unfertilized eggs (Goldstone et al., 2010) and in notochord (Thisse and Thisse, 2004) of 
developing zebrafish, and during embryonic development of mouse (Choudhary et al., 
2003).
An important observation derives from conditions associated with a microdeletion on 
chromosome 2 in humans. Patients diagnosed with microdeletions in the 2q33 chromosome 
region where CYP20A1 is located variously show psychomotor retardation, hyperactivity 
and bouts of anxiety, among other conditions (Balasubramanian et al., 2011; Tomaszewska 
et al., 2013). The observations together suggest participation of CYP20A1 early in 
vertebrate development, and possible involvement in brain functions and behavior. 
However, these possibilities have not been examined experimentally.
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In the present study, we employed zebrafish to examine features of CYP20A1 that could 
bear on its functions. Zebrafish CYP20A1 was cloned and sequenced, and the inferred 
primary structure was compared to that of the cloned human enzyme, and to CYP20A1 
coding sequences found in vertebrate genomes. We determined the organ distribution of 
transcript in adult zebrafish, and analyzed the transcriptional responses to agonists for 
several nuclear receptors and the aryl hydrocarbon receptor (AHR) that are prominent in 
regulating expression of a number of CYP genes in vertebrates (Honkakoski and Negishi, 
2000). The latter analysis was complemented by a search for putative binding sites recurring 
in proximal promoters of vertebrate CYP20A1 genes. We also conducted studies of 
CYP20A1 mRNA expression in zebrafish embryos with the potent environmental toxicant 
methylmercury (MeHg). Finally, early-developing zebrafish were screened for 
morphological and behavioral effects resulting from knockdown of CYP20A1 expression 
using morpholine-substituted oligonucleotides. The results together provide new information 
and perspective on the regulation and function of CYP20A1, including possible involvement 
in neurobehavioral disorders, and the effects of chemicals linked to such disorders.
Material and Methods
Animals
Experiments were conducted on early-developing and sexually mature zebrafish (Danio 
rerio) of the Tupfel Long-fin (TL), Tropical 5D and AB strains, and were approved by the 
Animal Care and Use Committee of the Woods Hole Oceanographic Institution, Oregon 
State University and Universite Catholique de Louvain, respectively. The associated Animal 
Welfare Assurance Numbers are respectively A3630-01, A3229-01 and 1458701. Fish were 
euthanized by immersion in a bath of tricaine methanesulfonate. Fish maintenance and 
breeding procedures were previously described (Jonsson et al., 2007a; Jonsson et al., 
2007b). cDNA Cloning and Sequencing
Primers were designed in the proximal 5’ and 3’ untranslated regions of zebrafish CYP20A1 
transcript [GenBank: NM_213332.1]. Primer sequences were 5’-
CTGATGGTCATTGTAGACG-3’ (F) and 5’-TCATGGATGTTGGAGTGG-3’ (R). We 
used the Advantage 2 PCR kit from Clontech (Mountain View, USA) to amplify the coding 
sequence from TL zebrafish liver cDNA with 1 μM of each primer; the thermal profile was: 
94°C for 1 min, [94°C for 30 sec, 58°C for 3 min] for 35 cycles, and 68°C for 7 min. PCR 
products were purified with the QIAquick Gel Extraction Kit from Qiagen (Valencia, USA) 
and cloned into pGEM-T Easy from Promega (Madison, USA) as per kit instructions. 
Mach-1 competent cells from Invitrogen (Carlsbad, USA) were transformed, and, following 
overnight incubation of selected ampicillin-resistant white colonies in liquid Luria-Bertani 
medium with antibiotic, plasmids were isolated with the QIAprep Spin Miniprep Kit from 
Qiagen (Valencia, USA). Three clones were sent to Eurofins MWG Operon (Louisville, 
USA) for forward and reverse sequencing with T7 primers (1 μg of plasmid DNA), and the 
full-length sequence was then assembled and aligned with [GenBank: NM_213332.1] using 
MacVector 12.0.2 (Oxford Molecular Group, Madison, USA). Secondary structure 
prediction
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Amino acid sequences of CYP20A1 proteins were retrieved from the Ensembl database 
(Flicek et al., 2013) and aligned with MacVector 12.0.2 software (Oxford Molecular Group, 
USA) (see Supplemental figure S1 for sequence identifiers). Note that the protein sequence 
inferred from the TL zebrafish transcript we cloned was fully identical to that predicted from 
the genome [Ensembl: ENSDARP00000003222]. The specific motifs of CYP20A1 
secondary structure (i.e. α-helices, β-strands, transmembrane domain, signal peptide) were 
predicted with two different online softwares, and overlapping predictions were chosen to 
construct the consensual secondary structure of the orphan P450. The α-helices were 
predicted with NetSurfP 1.1 (Petersen et al., 2009) and Psipred 3.0 (Bryson et al., 2005) at a 
cut-off of 80%. Putative β strands were localized with PredictProtein (Rost et al., 2004) and 
BETApro (Cheng and Baldi, 2005) under default settings. Hypothetical transmembrane 
domains were identified with PredictProtein (Rost et al., 2004) and TMHMM 2.0 (Krogh et 
al., 2001) at a cut-off of 80%. The possible presence of a signal peptide in the N-terminal 
portion of CYP20A1 was investigated with pSORTII (Nakai and Horton, 1999) and SignalP 
4.1 (Petersen et al., 2011) under default settings. The locations of the P450 signature motifs 
(i.e., I helix, K helix and heme-binding region) were analyzed based on the information 
available in reviews (Sezutsu et al., 2013; Werck-Reichhart and Feyereisen, 2000). The 
motifs specific to zebrafish and human CYP20A1 protein also were compared to those of all 
other zebrafish and human protein-coding CYPs available in the Ensembl database (data not 
shown). A subset of the zebrafish CYPs was used as basis for the comparison of CYP20A1 
signature motifs shown in Table 1. The sequence identifiers for the selected non-CYP20 
isoforms are shown in Supplemental table S6. CYP20A1 heterologous protein expression
Zebrafish CYP20A1 was heterologously expressed in E. coli, as before (Barnes et al., 1991). 
In essence, expression was obtained by replacing the putative membrane anchor N-terminal 
region with a membrane anchor from Bos taurus CYP17A1. Preparation of the samples and 
spectrophotometric analysis of the reduced, CO-ligated protein was done as before 
(Morrison et al., 2014).
In silico promoter analysis
The proximal promoter regions of CYP20A1s from the zebrafish, frog, chicken, rat and 
human were screened to identify putative binding sites for transcription factors (TFs) 
possibly involved in regulation of the orphan P450. Information on gene sequence was 
retrieved from the Ensembl database (Flicek et al., 2013). However, in the case of X. 
tropicalis, we used assembly 7.1 from the Joint Genome Institute available through Xenbase 
(James-Zorn et al., 2013). A region of 10 kb upstream of the start codon was selected for 
analysis with MatInspector software (Cartharius et al., 2005). The 10kb proximal promoter 
regions of vertebrate CYP20A1 genes were searched with MatInspector for putative binding 
sites having either 100% core sequence identity to known human TF binding sites, or a less 
stringent 80% core sequence identity. The putative TF binding sites that occurred in 
common in the different species’ CYP20A1s were classified in two groups, one for nuclear 
receptor TFs and the other for non-nuclear receptor TFs. Data for the latter group were 
subjected to an additional analysis. That is, the Uniprot database (Bairoch et al., 2005) was 
interrogated to identify recurring gene ontology terms in the pool of these recurring non-
nuclear receptor TFs. Gene ontology information was retrieved for rat and human TFs 
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whenever possible. The database generated was interrogated to identify the cell types, 
biological systems and processes over-represented in this pool of non-nuclear receptor TFs.
Organ distribution
Transcript abundance was analyzed in various organs of TL zebrafish by means of 
quantitative real-time PCR (qPCR), using liver as a reference tissue. The protocol of fish 
dissection followed that of Gupta & Mullins (Gupta and Mullins, 2010), using MS-222 for 
euthanasia. For the first set of samples, 12 males and 12 females were dissected to obtain 
liver, intestine, gonad, heart, kidney, whole brain and eye; organs were pooled from four 
males and from four females, giving three pools for each sex. Statistical analyses were 
conducted on tissues of males and females separately. For the second set, 12 males were 
dissected and tissues pooled to obtain three pools each of liver, spleen, forebrain, midbrain, 
hindbrain and optic nerve. All samples were flash-frozen in liquid nitrogen upon collection 
and stored at −70°C until processing. RNA was extracted with the Aurum Total Fatty and 
Fibrous Tissue kit from Bio-Rad (Hercules, USA) as per kit instructions. Total RNA was 
quantified by spectrophotometry and purity checked with a Nanodrop ND-1000 
(Wilmington, USA) at OD260/280 and OD260/230. Reverse transcription of 1 μg (first set) or 
150 ng (second set) of total RNA was done with the iScript cDNA Synthesis kit from Bio-
Rad, as per kit instructions. QPCR were run on a MyIQ single-color real-time thermocycler 
with IQ Sybr green Supermix from Bio-Rad. The E-ΔΔCt method was used for relative 
quantification (Livak and Schmittgen, 2001), using the geometric mean of aryl hydrocarbon 
receptor nuclear translocator 2 (arnt2) and elongation factor 1 alpha (ef1α) Ct values for 
normalization (Kubota et al., 2013; Morrison et al., 2014). Primers were: 5’-
TACAGGAGGTGGAAGGAAAGGTG-3’ (F) and 5’-
GACGACCACCAAGGGCATAGATAAC-3’ (R) for CYP20A1.
Exposure to nuclear and cytosolic receptor agonists, and methylmercury
Experimental exposures of zebrafish to selected nuclear and xenobiotic receptor agonists 
were conducted on pools of 15 TL embryos, in 60 ml of 0.3X Danieau's solution. Exposures 
began at 24 hours post fertilization (hpf), and lasted 24 h (up to 48 hpf) or 48 h (up to 72 
hpf). Tested chemicals in solvent carrier (dimethylsulfoxide or ethanol) or solvent carrier 
alone were added at a final volume of 0.1%. Supplemental table S2 provides a list of the 
tested chemicals and their known action on nuclear or xenobiotic receptors in mammals and 
zebrafish, to the best of our knowledge. Ethanol was used as solvent only for exposures to 
α-tocopherol, arachidonic, docosahexaenoic and eicosapentaenoic acids. Exposures to 
photosensitive agonists were conducted for 24 h at nominal concentrations of 0.1 – 1 – 10 
μM. Other exposures were conducted for 48 h at 0.1 – 1 – 3.2 μM, except that PCB 126 was 
tested for 48 h at doses (1 – 10 – 32 nM) that elicit CYP1 induction in zebrafish without 
compromising viability (Jonsson et al., 2007a; Jonsson et al., 2007b). All chemicals were of 
≥ 95% purity. Following incubations, TL embryos were quickly washed with 0.3X 
Danieau's solution, frozen in liquid nitrogen and stored at −70C° until RNA extraction. 
Sample preparation and qPCR analysis were the same as used in the tissue distribution 
analysis, except that extraction was performed with Aurum Total RNA Mini kit. One μg of 
total RNA was used for reverse transcription.
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Experimental exposures of zebrafish to methylmercury (MeHg) chloride were conducted on 
pools of 15 AB embryos, in 60 ml of 1X E3 medium, at the Institute of Life Sciences 
(Universite Catholique de Louvain). Exposure to 10 and 50 μg l−1 MeHg began at 24 hpf 
and embryos were sampled at 48 hpf, a protocol that does not result in embryo mortality 
(Hassan et al. 2012). Solvent carrier was distilled water (0.1 % final volume). Following 
incubations, AB embryos were washed with E3 medium, frozen in liquid nitrogen and stored 
at −70°C until RNA extraction. We used the exact same procedure of RNA extraction and 
cDNA synthesis as for TL embryos above. The qPCR experiments were run on a StepOne 
Plus real-time thermocycler with SYBR Select Master Mix, both from Applied Biosystems. 
We confirmed that this change of qPCR protocol did not affect the specificity or efficiency 
of amplification using the same reference genes and method of relative quantification as in 
TL exposure studies above. Morpholino-based CYP20A1 knockdown
Fertilized zebrafish eggs were injected at the 2- to 4-cell stage with fluorescein-tagged 
morpholino oligonucleotides (MO) from Gene Tools (Philomath, USA), complementary to a 
region encompassing the CYP20A1 start codon (5’-
AATCTAGCATTTTTGCTTTTCAGGGA-3’). Morpholino knockdown is transient but 
effects can persist to 5 or more days post fertilization. Controls for the specificity of gene 
knockdown consisted of embryos injected with a control MO (5’-
CCTCTTACCTCAGTTACAATTTATA-3’), and non-injected embryos. Hence, three 
groups were defined for phenotyping studies, non-injected, control MO-injected, and 
CYP20A1 MO-injected fish. Microinjection of 2.1 nl of 0.18 mM MO followed the protocol 
previously described (Jonsson et al., 2007a). The efficacy of CYP20A1 MO to block 
translation of the CYP20A1 was verified by inhibition of in vitro protein synthesis with a 
TnT assay from Promega (the inhibition of in vitro synthesis was about 50%; see 
Supplemental Figure S2). We used only those embryos showing high-level fluorescence at 
24 hpf, indicating abundant MO in the embryo.
For the Optomotor and Movement Tracking behavioral studies with the TL strain (described 
below), larvae were taken from each separate clutch or batch of TL zebrafish and distributed 
into three groups (i.e., in non-injected, control MO-injected, and CYP20A1 MO-injected 
groups), with 30 individuals in each group. Initially, early-developing zebrafish were kept in 
0.3X Danieau's solution for three days and 72 hpf embryos were then transferred in system 
water. Larvae from each group were fed once at 4 days post-fertilization (dpf) with a 
mixture of spirulina and 30-μm Hathchfry Encapsulon diet from Argent (Redmond, USA). 
Behavior assays were conducted at 5 dpf. TL fish in the various groups were examined daily 
by microscopy for any morphological abnormalities
Optomotor assay
Six separate clutches or batches of TL zebrafish larvae were used to study the optomotor 
response (OMR). With each batch, OMR was assessed on 20 larvae from each of the non-
injected, control MO-injected, and CYP20A1 MO-injected groups. The 20 larvae were 
randomly selected from the 30 larvae in each group. A transparent test chamber (25 cm 
long), placed on top of a computer monitor, was filled with system water at 26.5 ± 1.5°C. A 
pattern of black and white stripes, moving with a period of 6.5 cm and a frequency of 0.5 
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Hz, was displayed on the monitor. Larvae were assayed individually. Since zebrafish 
respond to low spatial frequencies by low velocities of optomotor response (Maaswinkel and 
Li, 2003), individuals were tested over 1-min periods and distances travelled were recorded 
every 15 s. There were no signs of aliasing under these conditions, and the responsiveness 
and distance travelled by control larvae were not significantly increased when the frequency 
of wave motion was doubled (data not shown). All trials were conducted between 3:00 and 
7:00 PM, and larvae from one group were tested before those from the other two groups. To 
rule out a possible effect of time on the optomotor responses, three batches were tested, with 
the non-injected controls tested first and the CYP20A1 MO fish tested last, and three others 
were conducted in the reverse order. Similar patterns of OMR were observed in all 
experiments.
Movement tracking and activity quantitation
Behavioral studies were also conducted with TL zebrafish, using an automated video 
tracking system from ViewPoint Life Sciences (Montreal, Canada). For each experimental 
group (i.e., non-injected, control MO-injected, and CYP20A1 MO-injected), 8 larvae were 
randomly selected from among the 10 individuals that were not tested in the OMR assay. 
These larvae were transferred individually in the wells of a 24-well plate filled with 2 ml of 
system water (26.5 ± 1.5°C). Motion and activity were recorded in consecutive 10-min 
videos under white light illumination. The first session (tracking) was started 5 min after 
larvae were introduced in the plate. The second session (activity) was started 5 min after 
completion of the first recording. For the tracking experiment, thresholds were: 0.5 cm.s−1 
for large movement and 0.1 cm.s−1 for inactivity. For activity analysis, thresholds were 10 
pixels per frame for burst and 1 for freeze.
High-throughput Morphological assessment and Photomotor response
As noted above, analysis of the CYP20A1-MO effects on TL strain fish included a daily 
microscopic monitoring of morphology. We also addressed morphological phenotypes using 
a high-throughput approach, conducted at 24 hpf (1 day) and 120 hpf (5 days) on non-
injected, control MO-injected and CYP20A1 MO-injected Tropical 5D strain zebrafish at the 
Department of Environmental and Molecular Toxicology, Oregon State University. For this 
study, at 4 hours post-fertilization (hpf) chorions were removed enzymatically with pronase, 
and embryos individually transferred to the wells of a 96-well plate with 100 μl of embryo 
medium at 28°C. Plates were sealed and protected from light for up to 120 hpf (Truong et 
al., 2014). Tropical 5D zebrafish from each of the three experimental groups also were 
assessed at 24 hpf for photomotor response according to previously published procedures 
(Truong et al., 2014).
Statistical analyses
Statistical analyses for results obtained with the TL and AB strains were conducted at the α 
= 0.05 level of significance with the Statistica 7.1 package from Statsoft (Tulsa, USA). Data 
were tested for normality by Kolmogorov-Smirnov test, and for homoscedasticity by 
Levene's test. Since multiple independent experiments were necessary to investigate 
CYP20A1 expression at all doses of each chemical in exposure studies (except for MeHg), 
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qPCR data were compared by two-tailed Student's t-test with batch-specific solvent controls. 
The MeHg dose-response data were analyzed by one-way ANOVA followed by post hoc 
LSD Fisher's test. The non-parametric Kruskal-Wallis ANOVA, followed by Z-adjusted 
Mann-Whitney U test, was used for statistical analyses of the tissue distribution and OMR 
studies. Data for movement tracking and activity quantitation of TL larvae were analysed by 
one-way ANOVA followed by post-hoc LSD Fisher's test. Results were expressed either as 
mean ± SEM or mean ± SD, and graphs generated with Sigma Plot 8.0 software from Systat 
(San Jose, USA). Statistical analyses for results with Tropical 5D fish were conducted as 
before (Truong et al., 2014).
Results
Cloning and sequence analysis of zebrafish CYP20A1
Primers designed to the proximal 5’ and 3’ untranslated regions of zebrafish CYP20A1 
transcript were used to amplify a full-length coding sequence from the Tupfel Long-fin (TL) 
strain. A protocol with a low annealing temperature was selected to ensure that possible 
strain-specific polymorphism in the untranslated regions did not impede primer binding and 
PCR efficiency. A bright band of the expected size was obtained, and results of sequencing 
revealed that the transcript from the TL strain was fully identical to the cDNA sequence of 
zebrafish CYP20A1 available in various databases (GenBank: NM_213332.1; Ensembl: 
ENSDART00000019325). The inferred amino acid sequence of our cloned zebrafish 
CYP20A1 shares sequence identities ranging from 59-66 % with CYP20A1 found in 
genomes of tetrapods, and from 69-82% with CYP20A1 from genomes of other fishes 
(Supplemental table S1). Such percentages were to be expected for members of a given 
vertebrate P450 subfamily.
Sequence structure and P450 signature motifs
The amino acid sequence derived from the cloned zebrafish CYP20A1 and the cloned 
human CYP20A1 (Stark et al., 2008) are aligned in Fig. 1. Features of protein structure that 
are alpha-helices (n = 13), beta strands (n = 8) and P450 signature motifs (n = 3; see Table 1 
headings) were identified based on alignment with other protein-coding CYPs from human 
and in silico predictions. As shown in Fig. 1, a conserved N-terminal segment of about 30 
residues that comprises a transmembrane domain typical of microsomal P450s is found in 
human and zebrafish CYP20A1s. A signal peptide -perhaps targeting the protein to 
mitochondria- also is predicted to occur, just after the transmembrane domain. P450 
signature motifs are identified in the I-helix, the K helix and the heme-binding region. 
However, the amino acid sequences in two of these motifs have features that are unusual 
compared to most other animal CYPs. Thus, the I helix signature of zebrafish CYP20A1 (aa 
276-281, AGCVIT) diverges at the fourth and fifth positions, notably lacking the usually 
conserved Thr at the fifth position, which is involved in the protonation of oxygen during 
the P450 catalytic cycle (Sezutsu et al., 2013). The heme-binding region of the zebrafish 
CYP20A1 (aa 403-411, FSGSQACPE) is one residue shorter than in most P450s, and 
displays an unusual sequence around the conserved Cys that serves as the apical heme iron 
ligand. Similar divergence from typical P450 motifs is seen in the I-helix and heme binding 
peptide of human CYP20A1.
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The amino acid sequences of the cloned zebrafish and human CYP20A1s also were aligned 
with the CYP20A1s of selected other vertebrate species, gleaned from genome databases 
(Supplemental figure S1). This alignment showed the presence of a conserved N-terminal 
segment and the unusual sequence features of the I-helix and the heme binding motifs in 
these other species, similar to those in zebrafish and human.
We compared the amino acid sequences of the three signature motifs in zebrafish CYP20A1 
to those in other zebrafish CYP families (Table 1). Divergence at the fourth and fifth 
positions of the I helix motif like that in CYP20A1 appears as well in CYP7A1 (cholesterol 
7α-hydroxylase), CYP8A1 (prostacyclin synthase), CYP8B1 (sterol 12α-hydroxylase), and 
several related zebrafish orphan CYPs (i.e., CYP7C1, CYP8B2 and CYP8B3), as well as 
CYP39A1 (oxysterol 7α-hydroxylase). Thus, the fourth position of the I-helix motif in all of 
these P450s has a hydrophobic rather than an acidic residue, and the fifth position does not 
contain a Thr residue. Instead, an Asp residue is found in all of the above-mentionned CYPs 
except CYP20A1 (which has an Ile residue). Most of these other CYPs do have a Thr at the 
6th position, raising a question about whether that Thr might fulfill a role in proton transfer 
to the oxygen. However, CYP8A1 and CYP39A1 do not have a Thr at either the 5th or the 
6th positions.
Divergence from the classical motif of the heme-binding region was also identified for 
CYP7A1, CYP8A1, CYP8B1, CYP39A1 (Table 1), and the related CYP7 and CYP8 
orphans. However, these sequences were not identical to that seen in CYP20A1, which has a 
unique heme-binding region. Thus, among zebrafish P450s, CYP20A1 is the only isoform 
with one residue missing at the beginning of the motif, a glutamine (neutral residue) instead 
of a basic residue at the center of the motif, and a glutamic acid instead of a glycine (non 
polar residue) at the terminal position. The same features distinguish the CYP20A1 from 
other P450s in human.
CYP20A1 heterologous protein expression
Zebrafish CYP20A1 was heterologously expressed in E. coli to determine whether a protein 
with a native P450 spectrum could be obtained, given the unusual sequence features. A 
reduced CO-difference spectrum typical of P450 was obtained (Fig. 2), which indicates 
expression of native protein. The presence of a peak at 420 nm in the CO-difference 
spectrum indicates partial loss of the cysteine thiolate linkage to the heme, which is 
sometimes the result of protein misfolding of non-native (heterologous) proteins in E. coli. 
However, we also observed that the 450 nm peak was rapidly converted to 420 nm, which 
suggests that the ferrous – CO complex is unstable, a condition observed with prostacyclin 
synthase (CYP8A1), an enzyme that acts on substrates that carry their own oxygen (Yeh et 
al., 2005). We did examine the expressed protein for Type-1 (substrate) binding speotra with 
cholesterol and arachidonic acid, but these preliminary studies failed to detect any binding to 
recombinant zebrafish CYP20A1 (authors’ unpublished information).
Tissue distribution and developmental expression of CYP20A1
Real-time quantitative PCR (qPCR) analysis was used to determine levels of CYP20A1 
transcript in organs from male and female zebrafish. Two sets of samples were analyzed, 
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with tissues pooled from multiple individuals. In the first set, both males and females were 
examined. In females, there was a significantly higher level of expression in ovary and heart 
than liver, intestine, kidney, brain and eye (Fig. 3A). In corresponding male samples, 
transcript levels in testis were higher than in the other tissues examined, and levels of 
expression were lower in heart and eye than in liver or brain (Fig. 3B). In the second set, we 
examined organs from male only. Expression levels were compared in different parts of the 
brain (forebrain, midbrain and hindbrain), optic nerve, spleen and liver. CYP20A1 transcript 
was slightly more abundant in spleen and optic nerve than in the other tissues (Fig. 3C).
Earlier we had reported on the levels of most CYP transcripts during zebrafish development, 
covering the period from 3 to 48 hours hpf (Goldstone et al., 2010). However, the levels of 
CYP20A1 were not readily discernible in the figures in that report. Values for CYP20A1 
were extracted from the previous microarray data, showing that CYP20A1 transcript was 
more abundant in embryos during the segmentation period (12-24 hpf) (Supplemental Figure 
3).
Reponses to chemical treatment
Possible effects on CYP20A1 expression were assessed in zebrafish embryos that had been 
exposed to agonists for selected nuclear and xenobiotic receptors. Emphasis was put on 
agonists for receptors involved in steroid function (androgen, estrogen and glucocorticoid 
receptors - AR, ER, and GR respectively), cholesterol and lipid metabolism (liver X, 
farnesoid X and peroxisome-proliferator-activated receptors - LXR, FXR, and PPAR 
respectively), response to xenobiotics (pregnane X receptor, PXR, and the aryl hydrocarbon 
receptor, AHR), and morphogenesis (retinoic acid receptor RAR) (see Supplemental table 
S2). Dose-response studies with these chemicals were conducted in zebrafish embryos with 
exposure beginning at 24 hpf, and sampling at 48 or 72 hpf (i.e., exposure for 24 or 48 h). 
Significant but modest increases of transcript abundance (about 150% of solvent controls) 
were observed in embryos exposed for 48 hr to 1 μM of diethylstilbestrol (Fig. 4A), a known 
ER agonist in zebrafish, or T0901317 (Fig. 4B), a known LXR-FXR agonist in zebrafish. At 
the highest dose, farnesol isomers (FXR agonists in zebrafish) and pregnenolone (PXR 
agonist in zebrafish) also led to a mild increase (i.e., about 30%) of CYP20A1 mRNA 
content in embryos (48 h exposure) (Fig. 4B). A similar increase was detected in embryos 
exposed to 1 μM dexamethasone (Fig. 4A), a GR agonist in zebrafish. Slight yet significant 
increases of expression (i.e., 10-20%) were also observed with 10 μM of docosahexaenoic 
acid (24 h exposure) (Supplemental table S3), a PPAR agonist in zebrafish, 1 μM of 
pregnenolone and 3.2 μM of the AR agonist androstenedione (48 h exposures) (Fig. 4). 
Expression of CYP20A1 decreased by about 10-20% in embryos exposed to doses up to 3.2 
μM all-trans retinoic acid (24 h exposures) (Supplemental table S3), a RAR agonist in 
zebrafish. (At 10 μM, all-trans retinoic acid treatment resulted in 98% mortality.)
We also examined response to the non-ortho-substituted (dioxin-like) polychlorinated 
biphenyl (PCB) 126, an AHR agonist (Supplemental table S2). Exposures were for 48 h, 
from 24 to 72 hpf. Nanomolar doses of PCB 126, which are highly effective at inducing the 
target gene CYP1A in zebrafish (Jonsson et al., 2007b), did not elicit any change in 
CYP20A1 expression (not shown).
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To assess further the possible involvement of nuclear receptors and other transcription 
factors (TFs) in the regulation of CYP20A1 expression, we used an in silico search to predict 
putative TF binding sites. A 10 kb proximal promoter region of the zebrafish and human 
CYP20A1 genes was examined, along with the promoters of CYP20A1 predicted in genomes 
of several other vertebrate species (rat, chicken, frog). We screened these regions for the 
presence of possible binding sites (i.e., response elements) for nuclear and xenobiotic 
receptors. When restricting the search to putative binding sites exactly matching the human 
core sequences, several were found to occur in proximal promoters of all the vertebrate 
CYP20A1 genes examined. These response elements are for the vertebrate steroidogenic 
factor 1 (SF1), the estrogen receptors and estrogen-related receptors (ERs and ERRs), the 
retinoic acid receptor-related orphan receptor alpha (RORα), the peroxisome proliferator-
activated receptors (PPARs) and glucocorticoid receptor (GR) (Table 2). When a less 
stringent cut-off of core sequence similarity was applied (i.e., 80%), response elements were 
identified also for other nuclear receptors. These include the androgen receptor (AR), the 
progesterone receptor (PR), the farnesoid X receptor (FXR), the hepatocyte nuclear factor 4 
(HNF4) and the retinoid receptors (RAR and retinoid X receptor – RXR) (Supplemental 
table S4). At 70% core sequence identity, binding sites were identified for the liver X 
receptor (LXR) but not AHR (data not shown).
Proximal promoter analyses also identified putative binding sites for numerous TFs that 
were not nuclear or xenobiotic receptors. Gene ontology terms were compiled from the 
Uniprot database (Bairoch et al., 2005) for these recurring TFs, and keyword searches 
conducted to determine the proportion of TFs putatively involved in CYP20A1 regulation 
that were associated with a particular cell type, biological system or process. At 100% core 
sequence identity, TFs active in the brain, blood cells (among which 77% were notably 
involved in immunity; data not shown), skeletal system, eye, sensory system, germ cells and 
stem cells were over-represented, as were TFs involved in neurogenesis, cell migration, 
neurulation and anterior/posterior patterning. Wingless (Wnt), Smoothened and Notch were 
the major developmental signaling pathways represented (Supplemental Table S5). Similar 
observations (i.e., enrichment of ontology terms) were made at 80% core sequence identity 
(data not shown).
To assess the influence of environmental toxicants on CYP20A1 expression, we examined 
zebrafish embryos exposed to MeHg chloride (10 and 50 μg.l−1) from 24 and 48 hpf (Hassan 
et al., 2012). The MeHg elicited dose-dependent reduction in CYP20A1 mRNA levels in 
zebrafish embryos (Fig. 5). With the higher dose tested, CYP20A1 transcript abundance was 
less than half the level in solvent controls, and was significantly lower than the levels 
obtained with a 10 μg.l−1 dose (p = 0.048; not shown).
Knockdown of CYP20A1 and phenotypic effects
To gain insight into the function of CYP20A1 protein in zebrafish, we used a morpholino 
(MO) gene knockdown approach. Morpholinos targeted to the CYP20A1 translation start 
site, which inhibits CYP20A1 protein synthesis, were injected into 2- to 4-cell stage 
embryos and morphological and behavioral phenotypes screened at various times. In these 
studies we used two approaches, with different strains, for assessing morphological and 
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behavioral effects of MO treatment. With TL zebrafish, morphology was assessed daily 
daily, and no obvious effects were seen in fish that were uninjected, control MO-injected or 
CYP20A1 MO-injected. Morphology was examined also in a high-throughput analysis using 
the Tropical 5D wild-type strain. In those latter analyses embryos injected with coded 
CYP20A1 or control MOs, and non-injected controls, were examined in a blind test at 24 hpf 
and at five days post-fertilization (dpf). At 24 hpf, somites and notochord appeared normal 
in both control MO and CYP20A1 MO embryos. Viability was unaffected, however, 
CYP20A1 MO-injected embryos exhibited a delayed development (data not shown). There 
were no morphological abnormalities noticed at 5 dpf in either the control MO or the 
CYP20A1 MO groups, i.e., yolk sac, body axis, eye, snout, jaw, otic vesicle, heart, brain, 
fins, trunk, swim bladder, notochord, pigmentation and circulation appeared normal.
We examined behavioral effects of CYP20A1 knockdown in a blind test at an early stage of 
development, 24 hpf. For this assay, we employed the Tropical 5D strain injected with 
coded CYP20A1 MO or control MO as above, and movement (tail flexion) was examined in 
ovo (Truong et al., 2014). Analysis revealed a greater in ovo activity in the CYP20A1 MO 
treated embryos, in both the dark-baseline and light-excitatory phases (Figure 6).
For later stage behavioral studies, TL strain zebrafish (the strain from which CYP20A1 had 
been cloned) were injected with control or CYP20A1 MOs at the 2- to 4-cell stage and at 
five dpf were screened for an optomotor response, and for locomotory activity with an 
automated tracking system. Non-injected TL zebrafish embryos were similarly tested.
We first tested for the optomotor response (OMR), a test for visual responsiveness in which 
fish larvae follow waves of vertical black and white stripes displayed on the fish tank 
bottom. Larvae from the three experimental groups were tested individually over 1-min 
periods, and the distance they travelled was recorded every 15 s. On average, larvae in the 
CYP20A1 MO group travelled about 20% less distance than those injected with control MO, 
or not injected (Fig. 7A). A substantial number of larvae in the CYP20A1 MO group did not 
initiate an oriented movement after 15 or 30 s of stimulation, indicating latency or reduced 
responsiveness of these fish to the visual stimulus. The CYP20A1 MO treatment did not 
appear to affect the locomotory capacity of larvae that did respond to the stimulus, based on 
distances traveled per unit time once the response began.
We then investigated the spontaneous locomotory behavior of CYP20A1 MO-injected TL 
larvae, using an automated tracking system (Viewpoint Zebrabox). In three independent 
experiments, eight larvae from each group (CYP20A1 MO-injected, control MO-injected 
and, non-injected) were tested simultaneously in 24-well plates, under constant illumination. 
Two 10-min movies were recorded, one for tracking movement (locomotion or directed 
motion) and the other for “activity quantitation”, quantitation of general activity. In the 
directed motion assay,CYP20A1 MO-injected larvae spent significantly more time at high 
speed (≥ 0.5 cm.s−1) than either non-injected or control MO-injected larvae, and also 
travelled more distance at high speed (Fig. 7B). Hyperactivity or bursts of activity, evident 
as significantly longer periods of time they spent at a high activity state, were typical of 
these larvae. This was reflected also in the higher level of total activity, expressed as 
integrated values (Fig. 7C).
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In these studies, we cloned and sequenced the cDNA of CYP20A1 of the zebrafish TL strain 
and found it identical to the zebrafish CYP20A1 coding sequence available in databases, and 
with a high % identity to the cloned human CYP20A1. Unusual features of the CYP20A1 
sequence have been suggested before, based largely on inferences from genome sequences 
(Sezutsu et al., 2013). The comparison of cloned zebrafish and human CYP20A1s 
establishes that these unusual features are present in the expressed proteins from both 
species. Zebrafish and human CYP20A1s have a highly conserved N-terminal motif that not 
only contains the transmembrane domain typical of microsomal P450s, but also have an 
adjacent motif that could possibly act as a signal peptide for mitochondrial targeting. This 
suggests that CYP20A1s might have a bimodal distribution in the ER and mitochondria, 
similarly to some other vertebrate P450s (Avadhani et al., 2011). Further work is needed to 
determine whether there is dual subcellular localization of CYP20A1s.
The zebrafish CYP20A1 protein and the human ortholog contain a typical EXXR motif in 
the K-helix, thought to be required for proper folding and heme inclusion (Sezutsu et al., 
2013). However, the I-helix and heme-binding regions were found to diverge significantly 
from the classical P450 signature motifs. The absence of one residue at the beginning of the 
heme-binding motif, and the Glu instead of a conserved Gly at the terminal portion, are 
unique to CYP20A1 when compared to other vertebrate P450s. Replacement of a non polar 
(Gly) by a negatively charged (Glu) residue at the end of the heme-binding motif is 
intriguing considering that the site where this change occurs is thought to be in close vicinity 
to the catalytic Cys in the tertiary structure (Otyepka et al., 2007). The presence of a Gln 
residue at a central site of the heme-binding motif, where usually an Arg or His residue is 
found, is also intriguing. The signature Arg or His residue is responsible for the hydrogen 
bonding with one heme propionate (Otyepka et al., 2007). It has been suggested that these 
hydrogen bonds not only can influence the stability of hemeproteins, but also their reactivity 
and ligand selection (Ramos-Santana and Lopez-Garriga, 2012). Note that Gln is also able to 
generate a hydrogen bond with the heme propionate. These features imply there could be 
unusual catalytic properties of CYP20A1s, as previously suggested (Sezutsu et al., 2013). In 
preliminary studies we failed to detect any binding of cholesterol or arachidonic acid to 
recombinant zebrafish CYP20A1. Likewise, Stark et al. (Stark et al., 2007) did not detect 
any activity of human CYP20A1 with cholesterol or arachidonic acid or any of 9 other 
possible substrates, including neurotransmitters. However, in a proteomic mapping of 
cholesterol-interacting proteins CYP20A1 was identified as possibly interacting with trans-
sterol (Hulce et al., 2013). The success at expressing recombinant zebrafish CYP20A1 will 
facilitate the search for substrates, and could provide for engineering to test possible 
functions.
The divergence observed in the I-helix, especially the absence of the conserved threonine at 
the 5th position of the motif, is similar to what is observed in zebrafish and human CYP7s 
and CYP8s. These sequences differ from zebrafish CYP20A1 in having a Ser residue at the 
second position of the motif in most cases (although a Ser is present in human CYP20A1), a 
Gly residue at the fourth and an Asn residue at the fifth position. While the functional 
significance of these I-helix features of CYP20A1 is unknown, it is notable that the presence 
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of an Ile residue rather than Thr at the 5th position of the I-helix motif also occurs in human 
CYP5A1 (thromboxane synthase). Reverse-engineering experiments with human CYP5A1 
have demonstrated a specific role for the Ile residue in keeping rates of product formation by 
the enzyme at low levels (Meling et al., 2015). The tight control of catalysis by CYP5A1 
suggests that the Ile in CYP20A1 could perhaps act similarly to limit product formation by 
this enzyme. Thus, too much or too little CYP20A1 activity could be detrimental.
Tissue distribution in reproductive, immune and nervous systems
The tissue distribution of CYP20A1 transcript in zebrafish was somewhat different from that 
observed with rodents. Thus, in male mouse, abundant CYP20A1 expression was found in 
spleen, followed by skeletal muscle, brain, heart, lung, kidney, testis and liver (Choudhary et 
al., 2003). In male rat, CYP20A1 was most strongly expressed in liver, followed by lung, 
spleen, kidney, heart, brain and testis (Takiguchi et al., 2010). Regardless of these 
differences, studies with zebrafish, human (Stark et al., 2008) and rodents are consistent in 
pointing to relatively high-level expression for CYP20A1 in reproductive, immune and 
nervous tissues. These patterns are consistent with the putative TF binding sites in CYP20A1 
proximal promoters.
The tissue distribution in zebrafish brain and eye also suggests a role for CYP20A1 in 
development and maintenance and/or function of the nervous system, supporting the 
inference from high level expression in human hippocampus, substantia nigra and retinal 
pigment epithelium (Stark et al., 2008; Strunnikova et al., 2010). It also has been noted that 
traumatic injury to both hippocampus and retinal pigment epithelium resulted in significant 
up-regulation of CYP20A1 expression in these rodent tissues (Birnie et al., 2013; 
Hadziahmetovic et al., 2012). Our observation that the optomotor response was slowed in 
the MO knockdown larvae is consistent with some role in visual processes. Refining the 
localization of CYP20A1 expression in zebrafish brain is an objective for further studies.
The data on CYP20A1 expression in the literature also reveal an enrichment of the transcript 
in human neural progenitor cells derived from embryonic stem cells (Chan et al., 2015) and 
expression, along with a limited set of other CYP genes, in human cord blood hematopoietic 
and early progenitor cells (Xu et al., 2014) These observations support a role for CYP20A1 
at early stages of cell differentiation in some tissues.
Response to agonists for nuclear and xenobiotic receptors
At micromolar doses, agonists for some nuclear receptors modestly, but significantly, 
increased CYP20A1 transcript levels in zebrafish embryos. The responses conform to 
predictions based on the presence of cis-response elements in the proximal promoter region 
of CYP20A1s. In silico and in vivo studies point to regulation of CYP20A1 expression by 
nuclear receptors involved in steroid response, cholesterol and lipid metabolism, and down-
regulation by the morphogen all-trans retinoic acid.
Among NR agonists, the highest increases of CYP20A1 expression were seen with 
diethylstilbestrol (DES) and T0901317. In zebrafish, DES is a potent ER agonist (Gorelick 
and Halpern, 2011). In mammals, it also acts as an inverse agonist for ERRs (Coward et al., 
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2001). To our knowledge, there are no reports of antagonism of zebrafish ERRs by DES. 
However, putative binding sites were specifically predicted for ERRα in proximal promoters 
of the vertebrate CYP20A1s at a cut-off of 80% of the human core sequence identity. ERs 
exert functions in reproduction and neuronal protection (Dahlman-Wright et al., 2006), 
while ERRs control the diurnal expression of genes involved in fatty acid, cholesterol and 
bile acid metabolism (Giguere et al., 2011).
An increase of CYP20A1 expression in zebrafish embryos also was observed with T0901317 
exposure. T0901317 is a benzenesulfonamide that is a potent agonist for LXR in mammals, 
and also is an agonist for PXR and FXR (Houck et al., 2004; Mitro et al., 2007) and an 
inverse agonist for RORα, and RORγ (Kumar et al., 2010). T0901317 appears to be an 
agonist for zebrafish LXR and FXR, but not PXR (Krasowski et al., 2011; Reschly et al., 
2008). In silico studies predicts the presence of binding sites for FXR and RORα in 
promoters of vertebrate CYP20A1. A less stringent cut-off also identified binding sites for 
LXR (i.e., 70% similarity with human set of LXR binding sites). These observations suggest 
that a diversity of nuclear receptors could have been involved in the T0901317-mediated 
increase of CYP20A1 expression. The LXRs and FXR are involved in sterol and bile acid 
homeostasis (Kalaany and Mangelsdorf, 2006), while RORs, which bind cholesterol, exert 
functions in brain and eye development, and immunity (Jetten, 2009). In contrast, there was 
no effect on CYP20A1 expression by nanomolar doses of PCB 126, or 2,3,7,8-
tetrachlorodibenzodioxin (data not shown), pointing to a lack of involvement of the AHR. 
Immunoassay with antibodies to zebrafish CYP20A1 would help to define localization of 
protein and responses to chemical treatment.
CYP20A1 knockdown effects
The potential involvement of CYP20A1 in neurobehavioral disorders is indicated not only 
by the expression in zebrafish, rodent and human brain, but also by the effects of CYP20A1 
knockdown investigated here. Zebrafish embryos in which CYP20A1 translation was partly 
inhibited showed developmental delay at 24 hpf, and behavioral effects were evident at 1 
and 5 dpf. The latency in initiating an appropriate swimming response due to CYP20A1 
knockdown in the OMR assay can be described as a defective visuo-motor integration or 
coordination, or an increased anxiety (Kalueff et al., 2014), rather than an impaired 
locomotory capacity. Larvae of the CYP20A1 MO group also exhibited a substantial 
increase of activity and swimming speed compared to the two control groups in the 
automated tracking-and-activity experiments. The possibility that the confined settings of 
the multiwell plates elicited these phenotypes in the CYP20A1 knockdown fish cannot be 
ruled out; thus, these bursts of activity and higher swimming speeds could have been driven 
by anxiety (Maximino et al., 2010).
Intriguingly, these phenotypic effects of CYP20A1 knockdown in zebrafish are strongly 
reminiscent of those seen in human patients diagnosed with microdeletions in the 2q33 
chromosome region where CYP20A1 is located. Patients with this rare syndrome variously 
show psychomotor retardation, hyperactivity and bouts of anxiety, and a delayed visuomotor 
coordination was specifically reported once (Balasubramanian et al., 2011; Tomaszewska et 
al., 2013). Analyzing the specific regions deleted, which are displayed in Balasubramian et 
Lemaire et al. Page 15









al. (Balasubramanian et al., 2011), reveals that the majority of patients (5-6 of 7) with 
deletions that included CYP20A1 presented with hyperactivity, while this phenotype was 
rarely observed in patients with deletions that excluded CYP20A1 (1-3 of 13). The present 
results with knockdown of CYP20A1 in zebrafish, and the 2q33 microdeletion patients, 
suggests that this orphan P450 could well be involved in neurobehavioral hyperactivity.
Response to methylmercury
The possible effects of a neurotoxicant on CYP20A1 expression were assessed by exposing 
zebrafish embryos to MeHg, among the chemicals suggested to contribute to hyperactivity 
disorder (Grandjean and Landrigan, 2014). These experiments revealed a dose-dependent 
reduction of CYP20A1 transcript abundance following 24 h exposure of zebrafish, beginning 
at 24 hpf. The higher dose tested resulted in the strongest decline of CYP20A1 expression. 
Notably, the MeHg concentration threshold in human cord blood that is associated with the 
detection of behaviors typical of attention deficit hyperactivity disorder (ADHD) during 
childhood is very close to the lowest dose we tested (Boucher et al., 2012). Providing that 
this effect on CYP20A1 expression also occurs in human and translates into changes at the 
protein level, it is tempting to envisage a link between prenatal exposure to MeHg, 
CYP20A1 repression (with detrimental developmental consequences) and the onset of 
ADHD. We are investigating further the mechanism of the MeHg effect on CYP20A1, and 
how CYP20A1 may function in neurological processes. Such studies will include direct 
comparison of behavioral change and CYP20A1 expression following MeHg exposures, as 
well as CYP20A1 responses to other neurotoxicants.
Conclusion
In this study, we cloned and examined properties of the zebrafish orphan P450 CYP20A1. 
Peculiar structural features of zebrafish, human and other vertebrate CYP20A1s are clues to 
an unusual catalytic function. The expression patterns of CYP20A1 transcript, and putative 
transcription factor binding sites suggest potential involvement in reproductive, immune and 
neuronal functions, as well as steroid response, lipid and cholesterol metabolism. A possible 
involvement in neuronal processes is strongly indicated by the behavioral effects occurring 
in zebrafish larvae treated with a morpholino against CYP20A1. The effects of knockdown - 
especially hyperactivity - are reminiscent of those in humans who have a microdeletion that 
includes loss of CYP20A1 gene. The MeHg-mediated reduction of CYP20A1 transcript 
levels in zebrafish embryos points to the possibility that disruption of CYP20A1 expression 
may be involved in some neurobehavioral disorders. Studies of CYP20A1 expression with 
additional toxicants are underway. Future studies will investigate whether over-expression 
can reverse behavioral deficits seen with MO treatments or MeHg, or whether 
overexpression also could be detrimental, which could occur if tight regulation of the 
enzyme might be necessary. The results presented here together shed new light on the 
possible biological and toxicological significance of the orphan CYP20A1 that has thus far 
resisted “deorphanization”.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
AHR aryl hydrocarbon receptor
AR androgen receptor




ef1α elongation factor 1 alpha
ER estrogen receptor
ERR estrogen-related receptor
FXR farnesoid X receptor
GR glucocorticoid receptor
HNF4 hepatocyte nuclear factor 4
hpf hours post-fertilization







PXR pregnane X receptor
qPCR real-time quantitative PCR
RAR retinoic acid receptor
ROR RAR-related orphan receptor
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RXR retinoid X receptor
SF1 vertebrate steroidogenic factor
TF transcription factor
TL Tupfel Long-fin zebrafish strain
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The “orphan” CYP20A1 was cloned from zebrafish and its sequence analyzed.
Knockdown of CYP20A1 reduced an optomotor response and elicited bursts of activity.
Effects of knockdown resemble some features of a microdeletion of CYP20A1 in human.
Expression of CYP20A1 was downregulated by the neurotoxicant methylmercury.
CYP20A1 may be involved in neurobehavioral processes and effects of some 
chemicals. .
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Figure 1. Alignment of zebrafish and human CYP20A1 proteins
Locations of P450 signature motifs and predicted secondary structure are illustrated. Yellow 
boxes identify ahelices and blue boxes β-strands. Green line locates the position of the 
predicted transmembrane region, and dashed purple line that of a putative signaling peptide 
suggested to target the protein to mitochondria.
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Figure 2. Reduced, CO-difference spectrum of heterologously expressed zebrafish CYP20A1
Zebrafish CYP20A1 was expressed in E. coli cells after N-terminal modification. The 
reduced difference spectrum shows a peak at 450nm, as expected, as well as a peak at 420 
nm indicating partial loss of the cysteine thiolate linkage to the heme, possibly due to the 
non-native protein expression in E coli.
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Figure 3. Expression of CYP20A1 transcript in zebrafish tissues
For both sexes, transcript levels were measured by real-time quantitative PCR (qPCR) using 
a double reference gene approach (elongation factor 1α and aryl hydrocarbon receptor 
nuclear translocator 2), and data are expressed relative (i.e., fold change) to transcript 
content in liver. Pools of organs were prepared and qPCR was run on three pools each for 
females (Figure 3A) and males (Figure 3B). In the second set, qPCR was run on three pools 
from males only (Figure 3C). Data are presented as mean ± SD. Different letters indicate 
significant difference of expression in organs of males and females separately (Kruskal-
Wallis ANOVA with post-hoc Z-adjusted Mann-Whitney U test).
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Figure 4. Expression of CYP20A1 in zebrafish embryos exposed to agonists for nuclear receptors
(a) Responses to diethylstilbestrol (black), androstenedione (white), and dexamethasone 
(grey). (b) Responses to T0901317 (black), farnesol isomers (white), and 5-pregnen-3β-
ol-20-one (grey). Transcript levels were measured by real-time quantitative PCR (qPCR) 
using a double reference gene approach (elongation factor 1α and aryl hydrocarbon receptor 
nuclear translocator 2). Exposures were from 24 to 72 hours post-fertilization on pools of 15 
embryos in 60 ml of 0.3X Danieau's solution with 0.1% of dimethylsulfoxide as carrier. 
Results were expressed as fold change from results obtained with carrier alone. Data are 
presented as mean ± SD of 4 replicates. Since the various doses of each chemical were 
tested in separate experiments, analyses were conducted with a 2-tailed Student's t-test. 
Asterisks indicate levels of statistical significance (* for p ≤ 0.05; ** for p ≤ 0.01).
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Figure 5. Expression of CYP20A1 in zebrafish embryos exposed to methylmercury chloride
Transcript levels were measured by real-time quantitative PCR (qPCR) using a double 
reference gene approach (elongation factor 1 α and aryl hydrocarbon receptor nuclear 
translocator 2). Exposures were from 24 to 48 hours post-fertilization on pools of 15 
embryos in 60 ml of 1X E3 medium with 0.1% of distilled water as carrier. Results are 
expressed relative (i.e., fold change) to those obtained with carrier alone. Data are presented 
as mean ± SD of 4 replicates. Analysis of the difference in CYP20A1 expression from 
solvent controls was conducted with one-way ANOVA followed by post hoc LSD Fisher's 
test. Asterisks indicate levels of statistical significance (* for p ≤ 0.05; ** for p ≤ 0.01).
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Figure 6. In ovo tail flexion movement response in zebrafish embryos treated with CYP20A1 
morpholino
In ovo tail flexion movement was automatically analyzed at 24 hours post-fertilization in 
zebrafish embryos of the Tropical 5D wild-type strain after injection with CYP20A1 
morpholino (MO A) (top line) or control morpholino (MO B). Embryos that were not 
injected (Uninj) were also used in the blind test. Individuals were placed one per well of a 
96-well plate. The red vertical lines indicate the time of a single bright, visible flashlight. 
The Y-axis values are an index of tail flexion (i.e., pixel changes between successive 
frames), and the X-axis values are given in seconds. Asterisks and labels indicate the 
statistically significant hyperactivity associated with CYP20A1 morpholino in both the 
baseline (dark, un-stimulated) phase and in the first excitatory period (i.e., following first 
pulse of bright light), and with control morpholino in just the first excitatory period.
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Figure 7. Optomotor and locomotory effects of CYP20A1 knockdown in zebrafish larvae
TL embryos were injected at the two-to-four cell stage with a morpholino (MO) specific for 
CYP20A1 or a control morpholino (Ctrl MO). Batch-specific embryos that were not injected 
were also used (Non injected). Assays were conducted on 5 day-old fish. In the optomotor 
response study (OMR; Figure 7A), a sine wave of black and white stripes (6.5 cm 
periodicity; 0.5 Hz) was tested (20 larvae per replicate per group; tested individually) and 
the sum of the straight distances travelled was used to compare OMR between groups every 
15 s, up to 1 min. Upper and lower panels show results from the first time bins as 
percentages of the straight distance travelled relative to non-injected larvae. The automated 
ViewPoint Zebrabox® was used to track locomotion (Figure 7B) and activity (Figure 7C) of 
the larvae in 24-well plates under constant illumination. 8 larvae from each group were 
simultaneously tested in consecutive 10-minute movie sessions (one for movement tracking 
and one for activity quantitation). For movement tracking, thresholds were: 0.5 cm.s−1 for 
large and 0.1 for no movement. Upper and lower panels of Figure 7B respectively depict the 
time and distance travelled by larvae at high speed (i.e., ≥ 0.5 cm.s−1). For activity 
quantitation, thresholds were: 10 pixels per frame for burst and one for freeze. Upper and 
lower panels of Figure 7C respectively depict the time spent by larvae in a hyperactive state 
(i.e., ≥ 10 pixels per frame) and their total level of activity (i.e., area under curve). Data are 
presented as mean ± SEM of six replicates for OMR and three replicates for tracking and 
activity, and were analyzed with Kruskal-Wallis ANOVA followed by Z-adjusted Mann-
Whitney U test (OMR) or one-way ANOVA followed by post hoc LSD Fisher's test 
(tracking-and-activity). Differences of CYP20A1 MO groups from non-injected controls are 
indicated by asterisks, (* p ≤ 0.05; ** p ≤ 0.01) and from Ctrl MO by diamonds (◆ p ≤ 0.05; 
◆◆ p ≤ 0.01).
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Table 1
P450 signature motifs in CYP20A1 and other selected CYPs in zebrafish.
P450 isoform I helix motif [G/AGXE/DTX] K helix motif [EXXR] Heme binding motif [FXXGXR/HXCXG]
CYP20A1 AGCVIT ETVR F-SGSQACPE
CYP1A AGFDTI EIFR FGLGKRRCIG
CYP2AA2 AGTDTT EIQR FSLGPRACLG
CYP3C1 GGYETT ESMR FGLGPRNCIG
CYP5A1 AGYETS ESLR FGAGPRSCVG
CYP7A1 ASQGNT EAMR FGSGVTKCPG
CYP7C1 ASVGNT ESLR FGSGATQCPG
CYP8A1 VTQGNA ETLR WGTEDNLCPG
CYP8B1 ASQGNT ETLR WGAGTTMCPG
CYP8B2 ASQGNT ETLR WGAGTTMCPG
CYP8B3 ASQGNT ETLR WGAGTTMCPG
CYP11C1 GGVDTT ETLR FGFGSRQCVG
CYP39A1 ASLANA EAIR FGGGKNQCPG
CYP51 AGQHTS ETLR FGAGRHRCIG
Underlined residues in some CYP isoforms (including CYP20A1) are those differing from the classical P450 signature motif reported in the 
heading of each column. See sources in Table S6.
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Table 2
Recurring putative binding sites for families of nuclear receptors in proximal promoters of CYP20A1s in 
vertebrates.
Matrix family Danio rerio Xenopus tropicalis Gallus gallus Rattus norvegicus Homo sapiens
Steroidogenic Factor (V$SF1F) 2 11 9 6 6
Estrogen Response (V$EREF) 3 5 8 7 2
v-ERB and RAR-related Orphan Receptor Alpha 
(V$RORA)
3 5 5 7 13
Peroxisome Proliferator-activated Receptor (V
$PERO)
6 22 14 9 13
Glucocorticoid Response and Related (V$GREF) 8 12 14 14 7
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